The Analyzers: Single-cell Superheroes of Therapy Development
The Analyzers: Single-cell Superheroes of Therapy Development Supporting the single-cell revolution with rare, timely, annotated, and applicable biospecimens,…
Read MoreSanguine Adds Advanced Health Data Integration Capabilities that Further Enhance Translational Medical Research
Comprehensive and real-time electronic health records shorten study timelines and offer new product opportunities
Read MorePick Preferred Specimens to Perfect Immune Profiling
Simple, underappreciated solutions for reliable flow cytometry data and longitudinal study design Complex problems require custom and creative…
Read MorePowering Precise Protein Assays
Standardizing the procurement of translational biospecimens reduces variability and strengthens biomarker studies. “Slow is smooth, smooth…
Read MoreSanguine Biosciences Announces $10 Million Credit Financing from Catalio Capital Management to Fund Continued Growth
Capital infusion fast-tracks the development of apheresis-derived products critical to cell and gene therapy research and manufacturing.
Read MoreDetermining Microbiome Contributions Starts with Sample Collection
Get full value from multiomics data by considering the specimen source ‘A journey of a thousand miles begins…
Read MoreSanguine Biosciences Opens New Apheresis Donor Center in Los Angeles
Sangine will collect concentrated white blood cell biospecimens through apheresis from participants in Sanguine’s Southern California Patient Community…
Read MoreSanguine Opens New Apheresis Donor Center to Support Cell & Gene Therapy and Translational Research Initiatives
The facility in the heart of Los Angeles enables the delivery of the highest quality and most relevant…
Read MoreA Fast and Fresh Feature for Translational Research
Providing the freedom and flexibility to support effective translational research Who doesn’t want fast and fresh? While revolutionary…
Read MoreVIR Biotechnology, Inc. Partners With Sanguine For COVID-19 Treatment
Full article can be read here – published by The Boston Globe. In an urgent effort to develop…
Read More